|Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer|
NM Desouza, SF Riches, NJ Vanas, VA Morgan, SA Ashley, C Fisher, ...
Clinical radiology 63 (7), 774-782, 2008
|Combined use of diffusion-weighted MRI and^ 1H MR spectroscopy to increase accuracy in prostate cancer detection|
SA Reinsberg, GS Payne, SF Riches, S Ashley, JM Brewster, VA Morgan, ...
AMERICAN JOURNAL OF ROENTGENOLOGY-NEW SERIES- 188 (1), 91, 2007
|A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance|
NJ van As, NM de Souza, SF Riches, VA Morgan, SA Sohaib, ...
European urology 56 (6), 981-988, 2009
|Diffusion‐weighted imaging of the prostate and rectal wall: comparison of biexponential and monoexponential modelled diffusion and associated perfusion coefficients|
SF Riches, K Hawtin, EM Charles‐Edwards, NM De Souza
NMR in Biomedicine: An International Journal Devoted to the Development and …, 2009
|Relationship between imaging biomarkers of stage I cervical cancer and poor-prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images|
K Downey, SF Riches, VA Morgan, SL Giles, AD Attygalle, TE Ind, ...
American Journal of Roentgenology 200 (2), 314-320, 2013
|MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters|
SF Riches, GS Payne, VA Morgan, S Sandhu, C Fisher, M Germuska, ...
American journal of roentgenology 193 (6), 1583, 2009
|Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance|
VA Morgan, SF Riches, K Thomas, N Vanas, C Parker, S Giles, ...
The British journal of radiology 84 (997), 31-37, 2011
|Nine-year follow-up for a study of diffusion-weighted magnetic resonance imaging in a prospective prostate cancer active surveillance cohort|
DR Henderson, NM de Souza, K Thomas, SF Riches, VA Morgan, ...
European urology 69 (6), 1028-1033, 2016
|Diffusion-weighted MRI for locally recurrent prostate cancer after external beam radiotherapy|
VA Morgan, SF Riches, S Giles, D Dearnaley, NM deSouza
AJR-American Journal of Roentgenology 198 (3), 596, 2012
|Apparent diffusion coefficient as a predictive biomarker of prostate cancer progression: value of fast and slow diffusion components|
SL Giles, VA Morgan, SF Riches, K Thomas, C Parker, NM deSouza
AJR-American Journal of Roentgenology 196 (3), 586, 2011
|Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional …|
CJ Simpkin, VA Morgan, SL Giles, SF Riches, C Parker, NM DeSouza
The British Journal of Radiology 86 (1024), 20120469, 2013
|Measurements of occupational exposure to switched gradient and spatially‐varying magnetic fields in areas adjacent to 1.5 T clinical MRI systems|
SF Riches, DJ Collins, GD Charles‐Edwards, JC Shafford, J Cole, ...
Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2007
|Effect on therapeutic ratio of planning a boosted radiotherapy dose to the dominant intraprostatic tumour lesion within the prostate based on multifunctional MR parameters|
SF Riches, GS Payne, NM Desouza, D Dearnaley, VA Morgan, ...
The British journal of radiology 87 (1037), 20130813, 2014
|EU Directive 2004/40: field measurements of a 1.5 T clinical MR scanner|
SF Riches, DJ Collins, JW Scuffham, MO Leach
The British Journal of Radiology 80 (954), 483-487, 2007
|Multivariate modelling of prostate cancer combining magnetic resonance derived T2, diffusion, dynamic contrast-enhanced and spectroscopic parameters|
SF Riches, GS Payne, VA Morgan, D Dearnaley, S Morgan, M Partridge, ...
European Radiology 25, 1247-1256, 2015
|Validation of T2-and diffusion-weighted magnetic resonance imaging for mapping intra-prostatic tumour prior to focal boost dose-escalation using intensity-modulated …|
EJ Alexander, JR Murray, VA Morgan, SL Giles, SF Riches, S Hazell, ...
Radiotherapy and Oncology 141, 181-187, 2019
|Nine-year follow-up for a study of diffusion-weighted MRI in a prospective active surveillance cohort for prostate cancer.|
DR Henderson, NM DeSouza, K Thomas, VA Morgan, SF Riches, ...
Journal of Clinical Oncology 33 (15_suppl), 5043-5043, 2015
|Modelling Diffusion Data using a Stretched-Exponential Model: Pitfalls in Estimation Methodology|
M Orton, D Collins, S Riches, M Leach
Prostate 1, 1.2, 2007
|Optimal combined functional MR parameters to correctly identify tumour in the prostate|
S Riches, GS Payne, M Partridge, C Jameson, V Morgan
Proc Intl Soc Mag Reson Med 44, 100, 2013
|Planning a boosted ra-diotherapy dose to the dominant intraprostatic tumour lesion within the prostate as defined by multifunctional MR parameters|
SF Riches, GS Payne, NM DeSouza, S Morgan, D Dearnaley, V Morgan, ...
ISMRM, Salt Lake city, USA 100, 2013